Literature DB >> 21236236

Innate immunity in DNA vaccine with Toxoplasma gondii-heat shock protein 70 gene that induces DC activation and Th1 polarization.

Masayuki Makino1, Noriko Uemura, Masataka Moroda, Akitoshi Kikumura, Lian-Xun Piao, Rabie M Mohamed, Fumie Aosai.   

Abstract

Toxoplasma gondii-derived heat shock protein 70 (T.g.HSP70) is a tachyzoite-specific virulent molecule expressed before the death of hosts. We have already demonstrated the vaccine effects of T.g.HSP70 gene targeting peripheral epidermal or dermal dendritic cells (DC) to limit T. gondii loads in T. gondii-infected mice. In the present study, involvement of innate immunity in T.g.HSP70 gene vaccine-induced Th polarization at draining lymph nodes (dLN) of C57BL/6 (B6) mice and vaccine effects against toxoplasmosis have been evaluated. Compared to the mice unvaccinated or vaccinated with empty plasmid, CD11c(+) cells at the dLN from naïve B6 mice expressed prominent IL-12 mRNA after the T.g.HSP70 gene vaccine. Also, CD4(+) cells at the dLN from the mice expressed prominent interferon-γ, but not IL-4 or IL-17, mRNA at a maximum level at day 5 following vaccination. Thus, in vivo DC activation and successive early Th1 polarization were induced at the dLN of naïve mice by the T.g.HSP70 gene vaccine. The DC activation and Th1 polarization were observed at the dLN from wild type (WT) and Toll-like receptor (TLR) 2-deficient mice, but not TLR4-deficient mice with B6 background by the vaccine. This T.g.HSP70 gene vaccine-induced DC activation and Th1 polarization were also observed in TRIF-deficient mice, but not MyD88-deficient mice with B6 background indicating the involvement of TLR4/MyD88 signal transduction cascade in the vaccine effects with T.g.HSP70 gene. The T.g.HSP70 gene vaccine (twice at a 2-week interval) has been shown to limit T. gondii loads in the mesenteric LN of WT, TLR2-deficient and TRIF-deficient mice, but neither TLR4-deficient nor MyD88-deficient mice, at an acute phase of toxoplasmosis. The T.g.HSP70 gene vaccine also limited cyst number in the brains of WT, TLR2-deficient and TRIF-deficient mice, but not TLR4-deficient mice at a chronic phase of toxoplasmosis. Thus, innate immunity also has effects on the vaccine with T.g.HSP70 gene against acute and chronic phases of toxoplasmosis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236236     DOI: 10.1016/j.vaccine.2010.12.118

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Toxoplasma gondii infection inhibits Th17-mediated spontaneous development of arthritis in interleukin-1 receptor antagonist-deficient mice.

Authors:  Takuya Washino; Masataka Moroda; Yoichiro Iwakura; Fumie Aosai
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

2.  Compartmentalization of immune responses during Staphylococcus aureus cranial bone flap infection.

Authors:  Joseph Cheatle; Amy Aldrich; William E Thorell; Michael D Boska; Tammy Kielian
Journal:  Am J Pathol       Date:  2013-06-07       Impact factor: 4.307

3.  The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice.

Authors:  Mona M El Temsahy; Eman D H El Kerdany; Maha M Eissa; Thanaa I Shalaby; Iman M Talaat; Nermine M F H Mogahed
Journal:  J Parasit Dis       Date:  2014-09-05

4.  Interleukin-10 Serum Levels after Vaccination with In Vivo Prepared Toxoplasma gondii Excreted/Secreted Antigens.

Authors:  Seyed Hossein Abdollahi; Fateme Ayoobi; Hossein Khorramdelazad; Gholamhossein Hassanshahi; Behzad Nasiri Ahmadabadi; Mohammadtaghi Rezayati; Ali Ravary; Ali Shamsizadeh; Mohammad Kazemi Arababadi
Journal:  Oman Med J       Date:  2013-03

Review 5.  SNPs in toll-like receptor (TLR) genes as new genetic alterations associated with congenital toxoplasmosis?

Authors:  W Wujcicka; J Wilczyński; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-17       Impact factor: 3.267

6.  TLR2 mediates immunity to experimental cysticercosis.

Authors:  José L Reyes; Marisol I González; Yadira Ledesma-Soto; Abhay R Satoskar; Luis I Terrazas
Journal:  Int J Biol Sci       Date:  2011-10-25       Impact factor: 6.580

7.  Levels of Transforming Growth Factor-Beta After Immunization of Mice With in vivo prepared Toxoplasma gondii Excretory/Secretory Proteins.

Authors:  Seyed Hossein Abdollahi; Fateme Ayoobi; Hossein Khorramdelazad; Behzad Nasiri Ahmadabadi; Mohammadtaghi Rezayati; Mohammad Kazemi Arababadi; Mohammad Zare-Bidaki
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

8.  Immunization of C57BL/6 Mice with GRA2 Combined with MPL Conferred Partial Immune Protection against Toxoplasma gondii

Authors:  Jalal Babaie; Samira Amiri; Robab Homayoun; Ebrahim Azimi; Reyhaneh Mohabati; Mahboobe Berizi; M. Reza Sadaie; Majid Golkar
Journal:  Iran Biomed J       Date:  2017-06-25

9.  Recombinant TgHSP70 Immunization Protects against Toxoplasma gondii Brain Cyst Formation by Enhancing Inducible Nitric Oxide Expression.

Authors:  Paulo Czarnewski; Ester C B Araújo; Mário C Oliveira; Tiago W P Mineo; Neide M Silva
Journal:  Front Cell Infect Microbiol       Date:  2017-04-25       Impact factor: 5.293

10.  Heat shock proteins: conditional mediators of inflammation in tumor immunity.

Authors:  Stuart K Calderwood; Ayesha Murshid; Jianlin Gong
Journal:  Front Immunol       Date:  2012-04-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.